Airway Inflammation and Host Responses in the Era of CFTR Modulators
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Airway Inflammation and Host Responses in the Era of CFTR Modulators
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 17, Pages 6379
Publisher
MDPI AG
Online
2020-09-02
DOI
10.3390/ijms21176379
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
- (2020) Heledd H Jarosz-Griffiths et al. eLife
- Treatment of Cystic Fibrosis Patients Homozygous for F508del with Lumacaftor-Ivacaftor (Orkambi®) Restores Defective CFTR Channel Function in Circulating Mononuclear Cells
- (2020) Maria Favia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation
- (2020) Guadalupe Ortiz-Muñoz et al. JOURNAL OF CLINICAL INVESTIGATION
- The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients
- (2020) Romee Gostelie et al. PLoS One
- CFTR Modulators Dampen Aspergillus-Induced Reactive Oxygen Species Production by Cystic Fibrosis Phagocytes
- (2020) Alexander J. Currie et al. Frontiers in Cellular and Infection Microbiology
- Deletion of cftr Leads to an Excessive Neutrophilic Response and Defective Tissue Repair in a Zebrafish Model of Sterile Inflammation
- (2020) Audrey Bernut et al. Frontiers in Immunology
- Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation
- (2019) Meraj A. Khan et al. Genes
- In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis
- (2019) Xingshen Sun et al. Science Translational Medicine
- The cumulative effect of inflammation and infection on structural lung disease in early CF
- (2019) Tim Rosenow et al. EUROPEAN RESPIRATORY JOURNAL
- Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis
- (2019) Charles R. Esther et al. Science Translational Medicine
- Phenotyping ciliary dynamics and coordination in response to CFTR-modulators in Cystic Fibrosis respiratory epithelial cells
- (2019) M. Chioccioli et al. Nature Communications
- Clinically approved CFTR modulators rescue Nrf2 dysfunction in cystic fibrosis airway epithelia
- (2019) Dana C. Borcherding et al. JOURNAL OF CLINICAL INVESTIGATION
- A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic Fibrosis
- (2019) Al-Rahim R. Habib et al. Scientific Reports
- Specific Inhibition of the NLRP3 Inflammasome as an Anti-Inflammatory Strategy in Cystic Fibrosis
- (2019) Oliver J McElvaney et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- IL-1β dominates the promucin secretory cytokine profile in cystic fibrosis
- (2019) Gang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Revealing the molecular signaling pathways of mucus stasis in cystic fibrosis
- (2019) Susan E. Birket et al. JOURNAL OF CLINICAL INVESTIGATION
- Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis
- (2019) Benjamin T. Kopp et al. Journal of Cystic Fibrosis
- The impact of CFTR modulator therapies on CF airway microbiology
- (2019) Geraint B. Rogers et al. Journal of Cystic Fibrosis
- The future of cystic fibrosis care: a global perspective
- (2019) Scott C Bell et al. Lancet Respiratory Medicine
- Metabolic Reprograming of Cystic Fibrosis Macrophages via the IRE1α Arm of the Unfolded Protein Response Results in Exacerbated Inflammation
- (2019) Samuel Lara-Reyna et al. Frontiers in Immunology
- Targeting Proteases in Cystic Fibrosis Lung Disease: Paradigms, Progress, and Potential
- (2019) Michael C McKelvey et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
- (2019) Harry G M Heijerman et al. LANCET
- Anti‐inflammatories and mucociliary clearance therapies in the age of CFTR modulators
- (2019) Lucy Perrem et al. PEDIATRIC PULMONOLOGY
- Vx-809/Vx-770 treatment reduces inflammatory response to Pseudomonas aeruginosa in primary differentiated cystic fibrosis bronchial epithelial cells
- (2018) Manon Ruffin et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa
- (2018) Roxanna Barnaby et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Infection Is Not Required for Mucoinflammatory Lung Disease in CFTR-Knockout Ferrets
- (2018) Bradley H. Rosen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Molecular principles for heparin oligosaccharide-based inhibition of neutrophil elastase in cystic fibrosis
- (2018) Apparao B. Kummarapurugu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ivacaftor withdrawal syndrome in cystic fibrosis patients with the G551D mutation
- (2018) Aaron T. Trimble et al. Journal of Cystic Fibrosis
- CFTR rescue with VX-809 and VX-770 favors the repair of primary airway epithelial cell cultures from patients with class II mutations in the presence of Pseudomonas aeruginosa exoproducts
- (2018) Damien Adam et al. Journal of Cystic Fibrosis
- EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis – Study design and patient demographics
- (2018) J. Stuart Elborn et al. Contemporary Clinical Trials
- VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
- (2018) Dominic Keating et al. NEW ENGLAND JOURNAL OF MEDICINE
- VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
- (2018) Jane C. Davies et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function
- (2018) Shuzhong Zhang et al. Scientific Reports
- Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation
- (2018) Chee Y. Ooi et al. Scientific Reports
- Activity of innate antimicrobial peptides and ivacaftor against clinical cystic fibrosis respiratory pathogens
- (2017) Joanna E. Payne et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters
- (2017) B. C. Millar et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- The effects of ivacaftor on CF fatty acid metabolism: An analysis from the GOAL study
- (2017) Michael Glenn O'Connor et al. Journal of Cystic Fibrosis
- Use of hyperpolarized helium-3 MRI to assess response to ivacaftor treatment in patients with cystic fibrosis
- (2017) Talissa A. Altes et al. Journal of Cystic Fibrosis
- CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis
- (2017) Abdullah A. Tarique et al. Journal of Cystic Fibrosis
- Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
- (2017) Jennifer L. Taylor-Cousar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poster Session Abstracts
- (2017) PEDIATRIC PULMONOLOGY
- Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis
- (2017) Robert D Gray et al. THORAX
- Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung Disease
- (2017) Michelle M. White et al. EBioMedicine
- Ivacaftor-Induced Proteomic Changes Suggest Monocyte Defects May Contribute to the Pathogenesis of Cystic Fibrosis
- (2016) Katherine B. Hisert et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Neutrophils from F508del cystic fibrosis patients produce IL-17A and express IL-23 - dependent IL-17RC
- (2016) Patricia R. Taylor et al. CLINICAL IMMUNOLOGY
- Alterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor
- (2016) Preston E. Bratcher et al. Journal of Cystic Fibrosis
- CFTR targeting during activation of human neutrophils
- (2016) Hang Pong Ng et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Cystic fibrosis
- (2016) J Stuart Elborn LANCET
- IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis
- (2016) Rossana G. Iannitti et al. Nature Communications
- An “Unlikely” Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI
- (2016) Elena K. Schneider et al. ACS Infectious Diseases
- Regulatory T-Cell Impairment in Cystic Fibrosis Patients with ChronicPseudomonasInfection
- (2015) Andreas Hector et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sustained Benefit from Ivacaftor Demonstrated by Combining Clinical Trial and Cystic Fibrosis Patient Registry Data
- (2015) Gregory S. Sawicki et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- 126 A phase 1 clinical study of CTX-4430 in cystic fibrosis patients
- (2015) E. Springman et al. Journal of Cystic Fibrosis
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation and its genesis in cystic fibrosis
- (2015) David P. Nichols et al. PEDIATRIC PULMONOLOGY
- Impact of the CFTR-Potentiator Ivacaftor on Airway Microbiota in Cystic Fibrosis Patients Carrying A G551D Mutation
- (2015) Cédric Bernarde et al. PLoS One
- Pseudomonas aeruginosa Reduces VX-809 Stimulated F508del-CFTR Chloride Secretion by Airway Epithelial Cells
- (2015) Bruce A. Stanton et al. PLoS One
- Lung microbiota across age and disease stage in cystic fibrosis
- (2015) Bryan Coburn et al. Scientific Reports
- Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
- (2014) Steven M. Rowe et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy
- (2014) K. Pohl et al. BLOOD
- Invariant Natural Killer T (iNKT) Cells Prevent Autoimmunity, but Induce Pulmonary Inflammation in Cystic Fibrosis
- (2014) Nanna Siegmann et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor
- (2014) Sonya L. Heltshe et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
- (2014) Kris De Boeck et al. Journal of Cystic Fibrosis
- Antibacterial properties of the CFTR potentiator ivacaftor
- (2014) Leah R. Reznikov et al. Journal of Cystic Fibrosis
- Neutrophil-Mediated Phagocytic Host Defense Defect in Myeloid Cftr-Inactivated Mice
- (2014) Hang Pong Ng et al. PLoS One
- A Th17- and Th2-skewed Cytokine Profile in Cystic Fibrosis Lungs Represents a Potential Risk Factor forPseudomonas aeruginosaInfection
- (2013) Kerstin Tiringer et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Reduced Caveolin-1 Promotes Hyperinflammation due to Abnormal Heme Oxygenase-1 Localization in Lipopolysaccharide-Challenged Macrophages with Dysfunctional Cystic Fibrosis Transmembrane Conductance Regulator
- (2013) P.-X. Zhang et al. JOURNAL OF IMMUNOLOGY
- Risk Factors for Bronchiectasis in Children with Cystic Fibrosis
- (2013) Peter D. Sly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantification of major urinary metabolites of PGE2 and PGD2 in cystic fibrosis: Correlation with disease severity
- (2013) Suha Jabr et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Intrinsic predisposition of naïve cystic fibrosis T cells to differentiate towards a Th17 phenotype
- (2013) Rahul Kushwah et al. RESPIRATORY RESEARCH
- Neutrophil Elastase Degrades Cystic Fibrosis Transmembrane Conductance Regulator via Calpains and Disables Channel FunctionIn VitroandIn Vivo
- (2012) Mathieu Le Gars et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Nitric Oxide and L-Arginine Deficiency in Cystic Fibrosis
- (2012) Hartmut Grasemann et al. CURRENT PHARMACEUTICAL DESIGN
- Improvement of defective cystic fibrosis airway epithelial wound repair after CFTR rescue
- (2012) Nguyen Thu Ngan Trinh et al. EUROPEAN RESPIRATORY JOURNAL
- Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia
- (2012) Guido Veit et al. MOLECULAR BIOLOGY OF THE CELL
- Regulation of inflammasome signaling
- (2012) Vijay A K Rathinam et al. NATURE IMMUNOLOGY
- Inflammasome-Mediated IL-1β Production in Humans with Cystic Fibrosis
- (2012) Anthony Tang et al. PLoS One
- S121 Lung Clearance Index to Evaluate the Effect of Ivacaftor on Lung Function in Subjects with CF Who Have the G551D-CFTR Mutation and Mild Lung Disease
- (2012) JCD Davies et al. THORAX
- Infection, Inflammation, and Lung Function Decline in Infants with Cystic Fibrosis
- (2011) Naveen Pillarisetti et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Role of CFTR expressed by neutrophils in modulating acute lung inflammation and injury in mice
- (2011) Xiao Su et al. INFLAMMATION RESEARCH
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dysfunctional CFTR Alters the Bactericidal Activity of Human Macrophages against Pseudomonas aeruginosa
- (2011) Paola Del Porto et al. PLoS One
- Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis
- (2011) S. C. Ranganathan et al. THORAX
- Lack of Cystic Fibrosis Transmembrane Conductance Regulator in CD3+Lymphocytes Leads to Aberrant Cytokine Secretion and Hyperinflammatory Adaptive Immune Responses
- (2010) Christian Mueller et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response
- (2010) Domenico Mattoscio et al. FASEB JOURNAL
- Loss of Cystic Fibrosis Transmembrane Conductance Regulator Function Enhances Activation of p38 and ERK MAPKs, Increasing Interleukin-6 Synthesis in Airway Epithelial Cells Exposed toPseudomonas aeruginosa
- (2010) Julie Bérubé et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Monocytes from children with clinically stable cystic fibrosis show enhanced expression of Toll-like receptor 4
- (2010) Nina C. Sturges et al. PEDIATRIC PULMONOLOGY
- Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
- (2010) Michael J. Cox et al. PLoS One
- Airway remodelling and its relationship to inflammation in cystic fibrosis
- (2010) N. Regamey et al. THORAX
- Lung Disease at Diagnosis in Infants with Cystic Fibrosis Detected by Newborn Screening
- (2009) Peter D. Sly et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Decreased Levels of Secretory Leucoprotease Inhibitor in the Pseudomonas-Infected Cystic Fibrosis Lung Are Due to Neutrophil Elastase Degradation
- (2009) S. Weldon et al. JOURNAL OF IMMUNOLOGY
- Bronchiectasis in Infants and Preschool Children Diagnosed with Cystic Fibrosis after Newborn Screening
- (2009) Stephen M. Stick et al. JOURNAL OF PEDIATRICS
- Macrophages Directly Contribute to the Exaggerated Inflammatory Response in Cystic Fibrosis Transmembrane Conductance Regulator−/−Mice
- (2008) Emanuela M. Bruscia et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A novel secreted protease from Pseudomonas aeruginosa activates NF-κB through protease-activated receptors
- (2008) Yutaka Kida et al. CELLULAR MICROBIOLOGY
- Elafin, an Elastase-specific Inhibitor, Is Cleaved by Its Cognate Enzyme Neutrophil Elastase in Sputum from Individuals with Cystic Fibrosis
- (2008) Nicolas Guyot et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis
- (2008) Volker Teichgräber et al. NATURE MEDICINE
- Dysfunction of Nrf-2 in CF Epithelia Leads to Excess Intracellular H2O2 and Inflammatory Cytokine Production
- (2008) Junnan Chen et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started